Clinical Trial

Inhaled Isopropyl Alcohol for Treatment of Nausea

Recruiting Phase 2/3
View on ClinicalTrials.gov →
Record status
This record was last updated October 8, 2025 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
To determine the efficacy of inhaled isopropyl alcohol in treating nausea/vomiting among pediatric patients compared with the conventional ondansetron, or placebo treatment in a tertiary care pediatric emergency department.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2022-06-12; most recent amendment 2025-10-03.
Trial Details
NCT Number NCT05418244
Lead Sponsor State University of New York at Buffalo
Conditions Vomiting, Nausea, Children, Only
Enrollment 84 participants
Start Date 2022-04-20
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-10-08